Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-19-022243
Filing Date
2019-11-06
Accepted
2019-11-06 17:27:20
Documents
10
Effectiveness Date
2019-11-06

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS defa14a110619_chinapharma.htm DEFA14A 67446
2 GRAPHIC image_001.jpg GRAPHIC 722
3 GRAPHIC image_002.jpg GRAPHIC 995
4 GRAPHIC image_003.jpg GRAPHIC 861
5 GRAPHIC image_004.jpg GRAPHIC 799
6 GRAPHIC image_005.jpg GRAPHIC 818
7 GRAPHIC image_006.jpg GRAPHIC 658
8 GRAPHIC image_007.jpg GRAPHIC 612
9 GRAPHIC image_008.jpg GRAPHIC 1151
10 GRAPHIC image_009.jpg GRAPHIC 9096
  Complete submission text file 0001213900-19-022243.txt   91690
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34471 | Film No.: 191197381
SIC: 2834 Pharmaceutical Preparations